Clinical experiences using radium-223, a novel α-emitting bone-seeking radiopharmaceutical, in breast and prostate cancer patients with skeletal metastases

被引：0
|
作者：
Nilsson, S
Larsen, RH
Bruland, OS
机构：
[1] Norwegian Radium Hosp, Oslo, Norway
[2] Algeta ASA, Oslo, Norway
[3] Karolinska Hosp, S-10401 Stockholm, Sweden
来源：
CANCER TREATMENT REVIEWS | 2005年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
51
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [31] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
    Vogelzang, Nicholas J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
  • [32] Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases
    Yamamoto, Yoshiyuki
    Okuda, Yohei
    Kanaki, Tomohiro
    Tanaka, Ryo
    Nagahara, Akira
    Nakai, Yasutomo
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Nishimura, Kazuo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 192 - 198
  • [33] Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases
    Yoshiyuki Yamamoto
    Yohei Okuda
    Tomohiro Kanaki
    Ryo Tanaka
    Akira Nagahara
    Yasutomo Nakai
    Masashi Nakayama
    Ken-ichi Kakimoto
    Kazuo Nishimura
    International Journal of Clinical Oncology, 2021, 26 : 192 - 198
  • [34] The palliative management of skeletal metastases in prostate cancer: Use of bone-seeking radionuclides and bisphosphonates
    Hamdy, NAT
    Papapoulos, SE
    SEMINARS IN NUCLEAR MEDICINE, 2001, 31 (01) : 62 - 68
  • [35] Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
    Matt Shirley
    Paul L. McCormack
    Drugs, 2014, 74 : 579 - 586
  • [36] Radium chloride [223Ra] for patients with prostate cancer and skeletal metastases. Clinical recommendations
    Kochetova, T. Yu
    Krylov, V. V.
    Petrosyan, K. M.
    Karyakin, O. B.
    Biryukov, V. A.
    Alekseev, B. Ya
    Matveev, V. B.
    Ivanov, S. A.
    Kaprin, A. D.
    ONKOUROLOGIYA, 2020, 16 (01): : 114 - 123
  • [37] Retrospective Toxicological Profiling of Radium-223 Dichloride for the Treatment of Bone Metastases in Prostate Cancer Using Adverse Event Data
    Soldatos, Theodoros G.
    Iakovou, Ioannis
    Sachpekidis, Christos
    MEDICINA-LITHUANIA, 2019, 55 (05):
  • [38] Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
    Shirley, Matt
    McCormack, Paul L.
    DRUGS, 2014, 74 (05) : 579 - 586
  • [39] Mechanisms of Bone Marrow Failure in Prostate Cancer Patients treated with Radium-223 Therapy
    Fiz, F.
    Campl, C.
    Sahbai, S.
    Schwanck, J.
    Weissinger, M.
    Bauckneht, M.
    Piva, R.
    Marini, C.
    Dittman, H.
    Piana, M.
    Sambuceti, G.
    La Fougere, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S329 - S330
  • [40] Investigation of the safety of Radium-223 chloride in combination with external beam radiotherapy for bone metastases of prostate cancer
    Makino, Soichi
    Miyazawa, Kazunari
    Katsuoka, Yoji
    Ooe, Takeru
    Aikawa, Ken
    Segawa, Akira
    Kobayashi, Hiroshi
    JOURNAL OF RADIATION RESEARCH, 2025,
12345